• There are no suggestions because the search field is empty.

Usability Testing and MDR: Managing Risk with the Human Factor

person-image
Caroline Aernouts, Senior Regulatory Specialist at QbD Group

Usability testing plays a key role in MDR compliance. Learn how early, structured testing helps reduce risk, improve device safety, and support regulatory approval.

Usability Testing and MDR: Managing Risk with the Human Factor | QbD Group
5:21

Under the EU Medical Device Regulation (MDR), usability is no longer a ‘nice-to-have’—it’s a core component of your risk management strategy. The MDR places strong emphasis on ensuring that medical devices are not only technically safe but also intuitive and effective in the hands of real users.

That means manufacturers must take human factors seriously, from early design through final validation to post-market surveillance. Usability testing helps identify and mitigate user-related risks and misuse, ultimately protecting patient safety and supporting smoother regulatory approval.

Why Usability Testing Matters Under MDR: Essential GSPRs

Several General Safety and Performance Requirements (GSPRs) make the connection clear. Usability testing directly supports:

 

  • GSPR 5: Minimizing risks related to ergonomic features and human factors.
  • GSPR 14.1 and 14.6: Ensuring safe and effective use through clear labeling and instructions.
  • GSPR 23(a): Providing comprehensive information for the user via labels and Instructions for Use (IFUs).

When devices are hard to understand or operate, the risk of use errors increases — and that’s a regulatory concern. Well-executed usability testing demonstrates that your product can be used safely and effectively, even in real-world conditions.

Usability engineering file expectations (according to IEC 62366-1)

To comply with MDR, manufacturers must maintain a usability engineering file that demonstrates user interactions have been thoroughly assessed and optimized. This documentation provides essential evidence that usability has been systematically addressed as part of the overall risk management process.

Key components typically include:

  • Use specifications: Clearly defined intended users, user environments, and use scenarios.
  • Risk analysis: Identification and mitigation of risks associated with potential use errors.

In addition to use-related risk management, the usability engineering file includes structured usability testing. This is typically divided into two key types:

 

Verification Testing – Are we building the product right?

  • Purpose: To ensure the system meets the design specifications and technical requirements.
  • Focus: Verifies that usability features were implemented as intended.
  • Example: Does the “Submit” button function correctly? Are navigation menus structured as planned?
  • Timing: Conducted during development (e.g., with early prototypes).

Validation Testing – Are we building the right product?

  • Purpose: To confirm that the device satisfies user needs and expectations under realistic conditions.
  • Focus: Evaluates how well real users can operate the device safely and effectively.
  • Example: Can users complete critical tasks without errors? Is the interface intuitive and user-friendly?
  • Timing: Conducted after development or with representative end-users in simulated use environments.

 

  • Final usability report: A summary of test results, documented mitigations, and any residual usability risks that remain.

The cost of timing: early vs. late usability testing

While usability testing is required, when you do it makes a significant difference. Early integration allows for proactive improvements, while late-stage testing may surface issues that are harder—and costlier—to fix.

 

Early-stage testing

  • Identifies potential use errors and ergonomic issues during the design phase.
  • Enables affordable design adjustments before full development.
  • Reduces downstream regulatory risks through early detection and resolution.

Late-stage testing

  • May reveal serious usability flaws when changes are complex and expensive.
  • Can delay time-to-market or lead to non-compliance findings.
  • Risks project overruns due to rework, retesting, and additional documentation.

Best practices for MDR-ready usability testing

To maximize the impact of your usability activities—and stay on the right side of MDR—consider these best practices:

 

  • Start early: Integrate usability testing into the earliest phases of product design.
  • Test iteratively: Run multiple usability sessions throughout development, not just at the end.
  • Document thoroughly: Include all user interactions, not just “critical” tasks, to demonstrate full lifecycle consideration.
  • Use representative users: Involve people who match your real-world user base to validate performance under realistic conditions.

These steps help ensure your usability file supports both safety and regulatory expectations, while also contributing to a more user-friendly product overall.

Conclusion: usability testing drives safer, more compliant devices

Usability testing isn’t just a regulatory obligation—it’s a key driver of product quality and user satisfaction. By prioritizing usability from the start, manufacturers can reduce risks, avoid late-stage redesigns, and improve their chances of MDR compliance.

QbD Group offers hands-on guidance to help you embed usability into your design and documentation processes—from user research and testing strategy to final validation and reporting.

Contact us to learn how we can support your device development journey.

 

Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short

Discover more expert content

preview_image
Whitepaper

Digitalization in the Pharmaceutical Industry: And How to Stay Compliant

Digitalization and Pharma 4.0 drive digital transformation. Explore the role of CSV in pharma's digital journey.
preview_image
Whitepaper

The Essential CSV & Digitalization FAQ for Life Sciences Companies

Get clear answers to real CSV questions from clients & experts. Download our FAQ and stay compliant, audit-ready, and confident in your Software Validation Strategy.
preview_image
Whitepaper

Audit Trail Review in GxP Environments

Learn how to implement a risk-based Audit Trail review strategy to enhance software compliance in GxP environments.
preview_image
Whitepaper

A Complete Guide to Computer System Validation

This guide aims to bring context and define the necessary and appropriate strategies for the validation of computerized systems. Download now.
preview_image
Whitepaper

Digital Health - Exploring the landscape and future opportunities

This whitepaper informs you about digital health, key technology pillars, and new opportunities to anticipate future trends in your healthcare sector.
preview_image
Whitepaper

How to keep computerized systems in the operational phase

Ensure compliance and efficiency with best practices for maintaining computerized systems in the operational phase. Download our expert whitepaper now!
preview_image
Webinar

From Requirements to Code: a unified MDSW development cycle that covers all requirements

Watch our webinar on demand to master medical device software development. Learn about IEC standards, cybersecurity, AI integration, and FDA expectations.
preview_image
Whitepaper

Mobile health on the rise: exploring the regulatory landscape for reimbursement

This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.
preview_image
Whitepaper

GAMP 5 Software Validation Approach for GMP, GCP and GLP regulations

Learn how to comply with GMP, GCP, and GLP regulations using the GAMP 5 Software Validation Approach. Download the whitepaper for more insights.
preview_image
Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.
preview_image
Whitepaper

Standards and regulations for software used in Medical Devices

Explore the essential standards and regulations for software used in Medical Devices, including IEC 62304 and IEC 82304. Download now.
preview_image
Whitepaper

Annual Product Quality Review in Pharma

Want to learn more about the importance, benefits, and key challenges related to the Annual Product Quality Review in Pharma? Then read on quickly!
preview_image
Whitepaper

21 CFR Part 11 compliance checklist

Want to assess whether a computer system generates electronic records and uses electronic signatures, and whether the system complies with Part 11 of 21 CFR? Download this free checklist.
preview_image
Webinar

Second edition of GAMP 5: A Risk-Based Approach to compliant GxP Computerized Systems

This webinar on demand will tell you more about the second edition of GAMP 5.
preview_image
Webinar

Verification & Validation of Artificial Intelligence/ Machine Learning Medical Devices

Explore the impact of Artificial Intelligence and Machine Learning on medical device validation and verification processes.
preview_image
Whitepaper

GAMP categories for computerized systems: what are they and what are they for?

In this whitepaper, you will learn what GAMP is, what GAMP categories are for, and where to start if you are facing computerized systems validation.
preview_image
Whitepaper

EUDRALEX Volume 4 Annex 11 Compliance Checklist

Assess your computer system's compliance with EudraLex Volume 4 Annex 11 guidelines using our checklist. Download now for GMP assurance.
preview_image
Whitepaper

From V-model to Agile: how to embrace automation as part of the computerized system validation approach

This white paper explores why IT is shifting to agile, focuses on the prevalent Scrum methodology, and concludes with guidance on adapting system validation processes.